The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Recurrent disease after liver transplant is a significant problem. Recurrent primary biliary cirrhosis (RPBC) is a histologic diagnosis. Clinical data is unreliable in predicting or diagnosing recurrence. RPBC appears to have a changing clinical presentation in recent years. MATERIALS AND METHODS: The diagnosis of RPBC after liver transplantation was made histologically. Data were obtained from our prospectively maintained liver-transplant database and evaluated statistically. RESULTS: Between 1985 and 1999, 1,835 liver transplants were performed, 169 for PBC. One hundred fifty-six patients were evaluated (one patient received retransplantation, and 13 were excluded). Seventeen (10.9%) experienced recurrence. Median posttransplantation follow-up time was 72.1 months. Median time to recurrence was 49.6 months. Median follow-up time after recurrence was 11.5 months. Neither acute rejection episodes (P=0.34) nor OKT3 use (P=0.36) before diagnosis of recurrence was significant. The combination of cyclosporine, azathioprine, and prednisolone demonstrated recurrence in 6 of 71 (8.4%). Six of 49 (12.2%) patients treated with cyclosporine with or without mycophenolate mofetil and prednisolone experienced recurrence. Six of 36 (16.7%) patients treated with tacrolimus and prednisolone with or without mycophenolate mofetil experienced recurrence. Patients treated with cyclosporine had numerically fewer recurrences than those treated with tacrolimus (P=0.11). CONCLUSIONS: Patients with RPBC demonstrated prolonged survival. Clinical factors did not aid in predicting RPBC. The clinical course of RPBC appears to be different than in the earlier years of liver transplantation. Immunosuppression may play a role. The use and type of antimetabolite drugs had no affect on recurrence. RPBC demonstrated a different clinical course with tacrolimus treatment (shorter time to recurrence) and increased incidence when compared with cyclosporine treatment. Controlled randomized studies are necessary to determine differences between tacrolimus and cyclosporine treatment, if any.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corpechot, C., Carrat, F., Bonnand, A.-M., Poupon, R. E., & Poupon, R. (2000) · Hepatology · doi:10.1053/jhep.2000.20240 · Cited by 316
Quality of life before and after liver transplantation for cholestatic liver disease
Gross, C. R., Malinchoc, M., Kim, R. W., Evans, R. W., Wiesner, R. H., Petz, J. L., Crippin, J. S., Klintmalm, G. B., Levy, M. F., Ricci, P., et al. (1999) · Hepatology · doi:10.1002/hep.510290229 · Cited by 192 · cited 1×
“The timing of transplantation must be optimized and performed before the point of rapid clinical deterioration, not only to save the patient’s life but also to improve the quality of life posttransplant (3).”
BackgroundSelf-citation
Cited by
Recurrence of autoimmune liver disease after liver transplantation: A systematic review
Gautam, M., Cheruvattath, R., & Balan, V. (2006) · Liver Transplantation · doi:10.1002/lt.20910 · Cited by 274
Lleo, A., Wang, G.-Q., Gershwin, M. E., & Hirschfield, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31607-x · Cited by 253
Autoimmune liver disease, autoimmunity and liver transplantation
Carbone, M., & Neuberger, J. M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.020 · Cited by 250
Recent advances in clinical practice: Epidemiology of autoimmune liver diseases
Trivedi, P. J., & Hirschfield, G. M. (2021) · Gut · doi:10.1136/gutjnl-2020-322362 · Cited by 244
Charatcharoenwitthaya, P., Pimentel, S., Talwalkar, J. A., Enders, F. T., Lindor, K. D., Krom, R. A. F., & Wiesner, R. H. (2007) · Liver Transplantation · doi:10.1002/lt.21124 · Cited by 179
“Several centers reported their anecdotal experience with UDCA.3,27,29 The present study dem- LIVER TRANSPLANTATION.”
ResultInfluential
Metadata
- Authors
- Sanchez, E. Q., Levy, M. F., Goldstein, R. M., Fasola, C. G., Tillery, G. W., Netto, G. J., Watkins, D. L., Weinstein, J. S., Murray, N. G., Byers, D., Christensen, L. L., & Klintmalm, G. B.
- Venue
- Transplantation
- Published
- 2003-12
- Volume
- 76
- Issue
- 11
- Pages
- 1583-1588
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W1991747215
- Cited by
- 113
- References
- 2
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation. https://app.cochat.ai/papers/10.1097/01.tp.0000090867.83666.f7
- The paper
- Sanchez, E. Q., Levy, M. F., Goldstein, R. M., Fasola, C. G., Tillery, G. W., Netto, G. J., Watkins, D. L., Weinstein, J. S., Murray, N. G., Byers, D., Christensen, L. L., & Klintmalm, G. B. (2003). The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation. Transplantation. https://doi.org/10.1097/01.tp.0000090867.83666.f7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.